Cas:91225-15-9 (4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate manufacturer & supplier

Chemical Name:(4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate

CAS.NO:91225-15-9

Synonyms:4-methylphenyl trans-4-(4-pentylcyclohexyl)benzoate

Molecular Formula:C₂₅H₃₂O₂

Molecular Weight:364.52000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:483.7ºC at 760 mmHg

Density:1.019

Index of Refraction:

PSA:26.30000

Exact Mass:364.24000

LogP:7.06830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-methylphenyl trans-4-(4-pentylcyclohexyl)benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methylphenyl trans-4-(4-pentylcyclohexyl)benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methylphenyl trans-4-(4-pentylcyclohexyl)benzoate Use and application,4-methylphenyl trans-4-(4-pentylcyclohexyl)benzoate technical grade,usp/ep/jp grade.

Related News: The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January. (4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate manufacturer The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January. (4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. (4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. (4-methylphenyl) 4-(4-pentylcyclohexyl)benzoate factory In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant.